HealthEquity Inc. (NASDAQ:HQY) insider Stephen Neeleman sold 30,000 shares of the firm’s stock in a transaction dated Tuesday, September 13th. The shares were sold at an average price of $33.22, for a total transaction of $996,600.00. Following the completion of the sale, the insider now owns 30,000 shares of the company’s stock, valued at approximately $996,600. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Stephen Neeleman also recently made the following trade(s):

  • On Tuesday, August 23rd, Stephen Neeleman sold 9,898 shares of HealthEquity stock. The shares were sold at an average price of $30.28, for a total transaction of $299,711.44.
  • On Thursday, August 18th, Stephen Neeleman sold 102 shares of HealthEquity stock. The shares were sold at an average price of $30.00, for a total transaction of $3,060.00.
  • On Wednesday, July 13th, Stephen Neeleman sold 30,000 shares of HealthEquity stock. The shares were sold at an average price of $30.52, for a total transaction of $915,600.00.
  • On Thursday, June 30th, Stephen Neeleman sold 17,967 shares of HealthEquity stock. The shares were sold at an average price of $30.20, for a total transaction of $542,603.40.

HealthEquity Inc. (NASDAQ:HQY) opened at 34.93 on Tuesday. The stock’s 50 day moving average is $31.17 and its 200-day moving average is $27.61. The stock has a market capitalization of $2.05 billion, a PE ratio of 89.56 and a beta of 1.65. HealthEquity Inc. has a 52 week low of $15.80 and a 52 week high of $35.78.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, September 6th. The company reported $0.16 earnings per share for the quarter, beating analysts’ consensus estimates of $0.13 by $0.03. HealthEquity had a net margin of 15.21% and a return on equity of 10.89%. The business earned $44.20 million during the quarter. During the same period in the prior year, the company earned $0.08 EPS. HealthEquity’s quarterly revenue was up 44.9% on a year-over-year basis. Equities research analysts forecast that HealthEquity Inc. will post $0.51 EPS for the current year.

Large investors have recently made changes to their positions in the stock. BlackRock Inc. increased its stake in shares of HealthEquity by 56.5% in the second quarter. BlackRock Inc. now owns 3,594 shares of the company’s stock worth $109,000 after buying an additional 1,297 shares in the last quarter. PineBridge Investments L.P. boosted its position in HealthEquity by 4.3% in the second quarter. PineBridge Investments L.P. now owns 4,482 shares of the company’s stock valued at $137,000 after buying an additional 186 shares during the period. Teacher Retirement System of Texas boosted its position in HealthEquity by 43.9% in the second quarter. Teacher Retirement System of Texas now owns 6,061 shares of the company’s stock valued at $184,000 after buying an additional 1,850 shares during the period. Denver Investment Advisors LLC purchased a new position in HealthEquity during the second quarter valued at approximately $203,000. Finally, Mason Street Advisors LLC purchased a new position in HealthEquity during the second quarter valued at approximately $210,000. 91.41% of the stock is owned by institutional investors and hedge funds.

A number of brokerages recently commented on HQY. Robert W. Baird raised their price objective on shares of HealthEquity from $31.00 to $35.00 and gave the company a “neutral” rating in a research report on Wednesday, September 7th. Zacks Investment Research downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a research report on Tuesday, June 14th. Wells Fargo & Co. restated a “buy” rating on shares of HealthEquity in a research report on Wednesday, June 8th. SunTrust Banks Inc. reiterated a “buy” rating on shares of HealthEquity in a research report on Thursday, September 8th. Finally, Barrington Research lifted their price target on shares of HealthEquity from $34.00 to $38.00 and gave the company an “outperform” rating in a research report on Thursday, September 8th. Three analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $36.00.

About HealthEquity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

5 Day Chart for NASDAQ:HQY

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.